Literature DB >> 28884664

Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study.

Stanley Langevin1,2, Maxime Pichon3,4,5, Elise Smith1, Juliet Morrison1, Zachary Bent2, Richard Green1, Kristi Barker1, Owen Solberg2, Yves Gillet6, Etienne Javouhey7, Bruno Lina4,3,5, Michael G Katze1,8, Laurence Josset5,4,3.   

Abstract

A few studies have highlighted the importance of the respiratory microbiome in modulating the frequency and outcome of viral respiratory infections. However, there are insufficient data on the use of microbial signatures as prognostic biomarkers to predict respiratory disease outcomes. In this study, we aimed to evaluate whether specific bacterial community compositions in the nasopharynx of children at the time of hospitalization are associated with different influenza clinical outcomes. We utilized retrospective nasopharyngeal (NP) samples (n=36) collected at the time of hospital arrival from children who were infected with influenza virus and had been symptomatic for less than 2 days. Based on their clinical course, children were classified into two groups: patients with mild influenza, and patients with severe respiratory or neurological complications. We implemented custom 16S rRNA gene sequencing, metagenomic sequencing and computational analysis workflows to classify the bacteria present in NP specimens at the species level. We found that increased bacterial diversity in the nasopharynx of children was strongly associated with influenza severity. In addition, patients with severe influenza had decreased relative abundance of Staphylococcus aureus and increased abundance of Prevotella (including P. melaninogenica), Streptobacillus, Porphyromonas, Granulicatella (including G. elegans), Veillonella (including V. dispar), Fusobacterium and Haemophilus in their nasopharynx. This pilot study provides proof-of-concept data for the use of microbial signatures as prognostic biomarkers of influenza outcomes. Further large prospective cohort studies are needed to refine and validate the performance of such microbial signatures in clinical settings.

Entities:  

Keywords:  biomarker; children; emergency unit; influenza; intensive care; microbiome

Mesh:

Substances:

Year:  2017        PMID: 28884664      PMCID: PMC7011740          DOI: 10.1099/jgv.0.000920

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  36 in total

1.  Endocarditis caused by Veillonella dispar.

Authors:  A C Loughrey; E W Chew
Journal:  J Infect       Date:  1990-11       Impact factor: 6.072

2.  Microbiota regulates immune defense against respiratory tract influenza A virus infection.

Authors:  Takeshi Ichinohe; Iris K Pang; Yosuke Kumamoto; David R Peaper; John H Ho; Thomas S Murray; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

3.  Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenza.

Authors:  Alexia Campbell; Rachel Rodin; Rhonda Kropp; Yang Mao; Zhiyong Hong; Julie Vachon; John Spika; Louise Pelletier
Journal:  CMAJ       Date:  2010-02-16       Impact factor: 8.262

4.  Anaerobic pulmonary infections.

Authors:  A Schreiner
Journal:  Scand J Infect Dis Suppl       Date:  1979

5.  Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection.

Authors:  Wouter A A de Steenhuijsen Piters; Santtu Heinonen; Raiza Hasrat; Eleonora Bunsow; Bennett Smith; Maria-Carmen Suarez-Arrabal; Damien Chaussabel; Daniel M Cohen; Elisabeth A M Sanders; Octavio Ramilo; Debby Bogaert; Asuncion Mejias
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

6.  Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load.

Authors:  Christine M Oshansky; Andrew J Gartland; Sook-San Wong; Trushar Jeevan; David Wang; Philippa L Roddam; Miguela A Caniza; Tomer Hertz; John P Devincenzo; Richard J Webby; Paul G Thomas
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

Review 7.  Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysis.

Authors:  Peter J Gill; Helen F Ashdown; Kay Wang; Carl Heneghan; Nia W Roberts; Anthony Harnden; Susan Mallett
Journal:  Lancet Respir Med       Date:  2014-12-04       Impact factor: 30.700

8.  phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data.

Authors:  Paul J McMurdie; Susan Holmes
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

9.  The vocabulary of microbiome research: a proposal.

Authors:  Julian R Marchesi; Jacques Ravel
Journal:  Microbiome       Date:  2015-07-30       Impact factor: 14.650

10.  Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis.

Authors:  Andrew D Fernandes; Jennifer Ns Reid; Jean M Macklaim; Thomas A McMurrough; David R Edgell; Gregory B Gloor
Journal:  Microbiome       Date:  2014-05-05       Impact factor: 14.650

View more
  19 in total

1.  Association Between the Respiratory Microbiome and Susceptibility to Influenza Virus Infection.

Authors:  Tim K Tsang; Kyu Han Lee; Betsy Foxman; Angel Balmaseda; Lionel Gresh; Nery Sanchez; Sergio Ojeda; Roger Lopez; Yang Yang; Guillermina Kuan; Aubree Gordon
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

2.  The mechanism on Prevotella melaninogenica promoting the inflammatory progression of oral lichen planus.

Authors:  Pan Xu; Ru-Ru Shao; Shi Zhang; Zheng-Wu Tan; Yi-Ting Guo; Yuan He
Journal:  Clin Exp Immunol       Date:  2022-08-19       Impact factor: 5.732

3.  The nasopharyngeal microbiota in patients with viral respiratory tract infections is enriched in bacterial pathogens.

Authors:  Sophie Edouard; Matthieu Million; Dipankar Bachar; Grégory Dubourg; Caroline Michelle; Laetitia Ninove; Rémi Charrel; Didier Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-22       Impact factor: 3.267

Review 4.  Impact of the Respiratory Microbiome on Host Responses to Respiratory Viral Infection.

Authors:  Maxime Pichon; Bruno Lina; Laurence Josset
Journal:  Vaccines (Basel)       Date:  2017-11-03

5.  Dolosigranulum pigrum Cooperation and Competition in Human Nasal Microbiota.

Authors:  Silvio D Brugger; Sara M Eslami; Melinda M Pettigrew; Isabel F Escapa; Matthew T Henke; Yong Kong; Katherine P Lemon
Journal:  mSphere       Date:  2020-09-09       Impact factor: 4.389

Review 6.  Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia.

Authors:  Shigeo Hanada; Mina Pirzadeh; Kyle Y Carver; Jane C Deng
Journal:  Front Immunol       Date:  2018-11-16       Impact factor: 7.561

7.  Comparison of the nasopharynx microbiome between influenza and non-influenza cases of severe acute respiratory infections: A pilot study.

Authors:  Luiz Gustavo Dos Anjos Borges; Adriana Giongo; Leandro de Mattos Pereira; Fernanda J Trindade; Tatiana Schäffer Gregianini; Fabrício Souza Campos; Elodie Ghedin; Ana Beatriz Gorini da Veiga
Journal:  Health Sci Rep       Date:  2018-05-09

8.  Progressive deterioration of the upper respiratory tract and the gut microbiomes in children during the early infection stages of COVID-19.

Authors:  Rong Xu; Pengcheng Liu; Tao Zhang; Qunfu Wu; Mei Zeng; Yingying Ma; Xia Jin; Jin Xu; Zhigang Zhang; Chiyu Zhang
Journal:  J Genet Genomics       Date:  2021-05-29       Impact factor: 4.275

9.  The human microbiome and COVID-19: A systematic review.

Authors:  Shinya Yamamoto; Makoto Saito; Azumi Tamura; Diki Prawisuda; Taketoshi Mizutani; Hiroshi Yotsuyanagi
Journal:  PLoS One       Date:  2021-06-23       Impact factor: 3.752

Review 10.  Microbiota Composition and the Integration of Exogenous and Endogenous Signals in Reactive Nasal Inflammation.

Authors:  Francesco Antonio Salzano; Luigi Marino; Giovanni Salzano; Riccardo Maria Botta; Giovanni Cascone; Umberto D'Agostino Fiorenza; Carmine Selleri; Vincenzo Casolaro
Journal:  J Immunol Res       Date:  2018-06-03       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.